glp-1 biosimilar As the use of medications continues to rise, researchers are exploring their potential impact on eye health. While these drugs can Biosimilar development requires a paradigm

To date, no clear clinical evidence has been found to suggest the tumorigenic effect of GLP-1RAs (226), whereas plenty of studies have indicated that GLP-1RAs can inhibit the growth of ovarian, breast, prostate, and pancreatic cancer (227, 228)

An early study showed that 250 M acetyl-l-carnitine did not affect axon regeneration but significantly reduced the rate of death of neurons from the DRG of aging rats, suggesting its neuroprotective action [14]

En un estudio adicional en pacientes con cncer terminal, los pacientes tratados con carnitina (dosis de 250 miligramos a 3000 miligramos/da) informaron una mejora en los sntomas de fatiga, as como una mejora en el estado de nimo y la calidad del sueo

Supporting natural GLP-1 function involves both increasing production (through diet and lifestyle) and managing degradation to extend the hormones active signaling window

PMID 34815532